Asclemed USA Inc. Dba Enovachem Pharmaceuticals FDA Record
- No warning letters matched by name
Asclemed USA Inc. Dba Enovachem Pharmaceuticals has 4 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Asclemed USA Inc. Dba Enovachem Pharmaceuticals" is on file.
- Latest recall
- D-0330-2021 · Class III · Mar 19, 2021
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 4 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Asclemed USA Inc. Dba Enovachem Pharmaceuticals: FDA recall records per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 1 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 3 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Asclemed USA Inc. Dba Enovachem Pharmaceuticals as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Asclemed USA Inc. Dba Enovachem Pharmaceuticals yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0330-2021 | Class III | Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count Blister, NDC… | Mar 19, 2021 |
| D-0652-2020 | Class II | Estriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD… | Dec 9, 2019 |
| D-0650-2020 | Class II | Estriol, USP, (Micronized), 0.06 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD… | Dec 9, 2019 |
| D-0651-2020 | Class II | Estriol, USP, (Micronized), 0.12 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD… | Dec 9, 2019 |
Asclemed USA Inc. Dba Enovachem Pharmaceuticals and the FDA: common questions
Has Asclemed USA Inc. Dba Enovachem Pharmaceuticals received an FDA warning letter?
No FDA warning letter addressed to the name "Asclemed USA Inc. Dba Enovachem Pharmaceuticals" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Asclemed USA Inc. Dba Enovachem Pharmaceuticals received an FDA Form 483?
FDA has not published a Form 483 for "Asclemed USA Inc. Dba Enovachem Pharmaceuticals" in its reading room. FDA publishes some Form 483s, not all of them.
Has Asclemed USA Inc. Dba Enovachem Pharmaceuticals had an FDA recall?
Yes. Asclemed USA Inc. Dba Enovachem Pharmaceuticals has 4 FDA recalls on record. The most recent started Mar 19, 2021.
Need more than this page shows? Ask about Asclemed USA Inc. Dba Enovachem Pharmaceuticals in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.